S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
NASDAQ:MASI

Masimo - MASI Stock Forecast, Price & News

$173.57
+0.69 (+0.40%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$173.27
$174.79
50-Day Range
$156.75
$182.43
52-Week Range
$108.89
$184.96
Volume
167,477 shs
Average Volume
354,138 shs
Market Capitalization
$9.13 billion
P/E Ratio
66.76
Dividend Yield
N/A
Price Target
$182.00

Masimo MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.88 Rating Score
Upside/​Downside
4.9% Upside
$182.00 Price Target
Short Interest
Healthy
1.85% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.86
Upright™ Environmental Score
News Sentiment
0.49mentions of Masimo in the last 14 days
Based on 14 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
10.95%
From $4.75 to $5.27 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.07 out of 5 stars

Medical Sector

328th out of 995 stocks

Electromedical Equipment Industry

4th out of 24 stocks


MASI stock logo

About Masimo (NASDAQ:MASI) Stock

Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet, Masimo Patient SafetyNet Surveillance, Masimo SafetyNet, Masimo SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridge. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.

Receive MASI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Masimo and its competitors with MarketBeat's FREE daily newsletter.

MASI Stock News Headlines

Banking Nightmare
During and after the Great Financial Crisis of 2008, 485 U.S. banks went under. Here at Weiss Ratings, we warned about 484 — an accuracy rate of 99.8%. Now, we have a new warning. But this time, it's not just about a few hundred banks … it's about nearly every single bank in America …
Masimo (NASDAQ:MASI) Now Covered by Analysts at StockNews.com
Banking Nightmare
During and after the Great Financial Crisis of 2008, 485 U.S. banks went under. Here at Weiss Ratings, we warned about 484 — an accuracy rate of 99.8%. Now, we have a new warning. But this time, it's not just about a few hundred banks … it's about nearly every single bank in America …
Masimo Co. (NASDAQ:MASI) Short Interest Update
Q4 2022 Masimo Corp Earnings Call
Expert Ratings for Masimo
See More Headlines
Receive MASI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Masimo and its competitors with MarketBeat's FREE daily newsletter.

MASI Company Calendar

Last Earnings
2/28/2023
Today
3/27/2023
Next Earnings (Estimated)
5/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:MASI
CUSIP
57479510
Employees
6,000
Year Founded
1989

Price Target and Rating

Average Stock Price Forecast
$182.00
High Stock Price Forecast
$206.00
Low Stock Price Forecast
$150.00
Forecasted Upside/Downside
+5.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.88
Research Coverage
8 Analysts

Profitability

Net Income
$143.50 million
Pretax Margin
9.50%

Debt

Sales & Book Value

Annual Sales
$2.04 billion
Cash Flow
$7.43 per share
Book Value
$25.45 per share

Miscellaneous

Free Float
47,500,000
Market Cap
$9.09 billion
Optionable
Optionable
Beta
0.86

Social Links


Key Executives

  • Joe E. KianiJoe E. Kiani
    Chairman & Chief Executive Officer
  • Bilal MuhsinBilal Muhsin
    Chief Operating Officer
  • Micah YoungMicah Young
    Chief Financial Officer & Executive Vice President
  • Yongsam Lee
    Chief Information Officer & Executive VP
  • Anand SampathAnand Sampath
    Executive VP-Operations & Clinical Research













MASI Stock - Frequently Asked Questions

Should I buy or sell Masimo stock right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last twelve months. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" MASI shares.
View MASI analyst ratings
or view top-rated stocks.

What is Masimo's stock price forecast for 2023?

8 equities research analysts have issued twelve-month price objectives for Masimo's shares. Their MASI share price forecasts range from $150.00 to $206.00. On average, they expect the company's stock price to reach $182.00 in the next twelve months. This suggests a possible upside of 5.3% from the stock's current price.
View analysts price targets for MASI
or view top-rated stocks among Wall Street analysts.

How have MASI shares performed in 2023?

Masimo's stock was trading at $147.95 at the start of the year. Since then, MASI shares have increased by 16.9% and is now trading at $172.88.
View the best growth stocks for 2023 here
.

When is Masimo's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 2nd 2023.
View our MASI earnings forecast
.

How were Masimo's earnings last quarter?

Masimo Co. (NASDAQ:MASI) posted its quarterly earnings results on Tuesday, February, 28th. The medical equipment provider reported $1.32 EPS for the quarter, topping analysts' consensus estimates of $1.17 by $0.15. The medical equipment provider had revenue of $617 million for the quarter, compared to the consensus estimate of $602.49 million. Masimo had a net margin of 7.06% and a trailing twelve-month return on equity of 18.84%. The firm's revenue was up 88.4% compared to the same quarter last year. During the same period in the previous year, the company posted $1.21 EPS.

What guidance has Masimo issued on next quarter's earnings?

Masimo issued an update on its first quarter 2023 earnings guidance on Tuesday, February, 28th. The company provided earnings per share guidance of $0.81-$0.86 for the period, compared to the consensus EPS estimate of $0.93. The company issued revenue guidance of $550.00 million-$565.00 million, compared to the consensus revenue estimate of $553.42 million.

What is Joe E. Kiani's approval rating as Masimo's CEO?

136 employees have rated Masimo Chief Executive Officer Joe E. Kiani on Glassdoor.com. Joe E. Kiani has an approval rating of 90% among the company's employees.

What other stocks do shareholders of Masimo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Netflix (NFLX), Shopify (SHOP), Okta (OKTA), PayPal (PYPL), Alibaba Group (BABA), Mastercard (MA), Trade Desk (TTD), Walt Disney (DIS) and Twilio (TWLO).

What is Masimo's stock symbol?

Masimo trades on the NASDAQ under the ticker symbol "MASI."

Who are Masimo's major shareholders?

Masimo's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Liontrust Investment Partners LLP (1.81%), Fundsmith LLP (1.45%), Geode Capital Management LLC (1.34%), Schroder Investment Management Group (1.10%), Martin Currie Ltd. (1.04%) and T. Rowe Price Investment Management Inc. (1.03%). Insiders that own company stock include Adam Mikkelson, Anand Sampath, Bilal Muhsin, Craig B Reynolds, H Michael Cohen, Joe E Kiani, Jon Coleman, Micah W Young, Ramshorst David J Van, Tao Levy, Thomas Samuel Mcclenahan and Yongsam Lee.
View institutional ownership trends
.

How do I buy shares of Masimo?

Shares of MASI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Masimo's stock price today?

One share of MASI stock can currently be purchased for approximately $172.88.

How much money does Masimo make?

Masimo (NASDAQ:MASI) has a market capitalization of $9.09 billion and generates $2.04 billion in revenue each year. The medical equipment provider earns $143.50 million in net income (profit) each year or $2.60 on an earnings per share basis.

How many employees does Masimo have?

The company employs 6,000 workers across the globe.

How can I contact Masimo?

Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The official website for the company is www.masimo.com. The medical equipment provider can be reached via phone at (949) 297-7000, via email at ekammerman@masimo.com, or via fax at 949-297-7001.

This page (NASDAQ:MASI) was last updated on 3/27/2023 by MarketBeat.com Staff